NO961743D0 - N-alkyl-peptid-chelatdannere, deres metallkomplekser med radionuklider, fremgangsmåte ved deres fremstilling og radiofarmasöytiske sammensetninger inneholdende disse forbindelser - Google Patents

N-alkyl-peptid-chelatdannere, deres metallkomplekser med radionuklider, fremgangsmåte ved deres fremstilling og radiofarmasöytiske sammensetninger inneholdende disse forbindelser

Info

Publication number
NO961743D0
NO961743D0 NO961743A NO961743A NO961743D0 NO 961743 D0 NO961743 D0 NO 961743D0 NO 961743 A NO961743 A NO 961743A NO 961743 A NO961743 A NO 961743A NO 961743 D0 NO961743 D0 NO 961743D0
Authority
NO
Norway
Prior art keywords
radionuclides
compounds
preparation
compositions containing
chelating agents
Prior art date
Application number
NO961743A
Other languages
English (en)
Other versions
NO961743L (no
Inventor
Hartmut Spies
Paul-Eberhard Schulze
Bernd Noll
Steffi Noll
Ludger Dinkelborg
Original Assignee
Diagnostikforschung Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostikforschung Inst filed Critical Diagnostikforschung Inst
Publication of NO961743D0 publication Critical patent/NO961743D0/no
Publication of NO961743L publication Critical patent/NO961743L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/26—Esters of monothiocarboxylic acids having carbon atoms of esterified thiocarboxyl groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO961743A 1993-11-01 1996-04-30 N-alkyl-peptid-chelatdannere, deres metallkomplekser med radionuklider, fremgangsmåte ved deres fremstilling og radiofarmasöytiske sammensetninger inneholdende disse forbindelser NO961743L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4337600A DE4337600A1 (de) 1993-11-01 1993-11-01 N-Alkyl-Peptidchelatbildner, deren Metallkomplexe mit Radionukliden, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende radiopharmazeutische Zusammesetzungen
PCT/DE1994/001295 WO1995012610A1 (de) 1993-11-01 1994-10-27 N-alkyl-peptidchelatbildner, deren metallkomplexe mit radionukliden, verfahren zu ihrer herstellung und diese verbindungen enthaltende radiopharmazeutische zusammensetzungen

Publications (2)

Publication Number Publication Date
NO961743D0 true NO961743D0 (no) 1996-04-30
NO961743L NO961743L (no) 1996-04-30

Family

ID=6501750

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961743A NO961743L (no) 1993-11-01 1996-04-30 N-alkyl-peptid-chelatdannere, deres metallkomplekser med radionuklider, fremgangsmåte ved deres fremstilling og radiofarmasöytiske sammensetninger inneholdende disse forbindelser

Country Status (11)

Country Link
EP (1) EP0726909A1 (no)
JP (1) JPH09508351A (no)
KR (1) KR960705842A (no)
CN (1) CN1134158A (no)
AU (1) AU681919B2 (no)
CA (1) CA2173844A1 (no)
DE (1) DE4337600A1 (no)
HU (1) HUT74881A (no)
NO (1) NO961743L (no)
WO (1) WO1995012610A1 (no)
ZA (1) ZA948411B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
US6162378A (en) * 1999-02-25 2000-12-19 3D Systems, Inc. Method and apparatus for variably controlling the temperature in a selective deposition modeling environment
US6171578B1 (en) 1999-04-14 2001-01-09 Diatide, Inc. Benzodiazepine derivatives for imaging thrombi
CA2408408C (en) 2000-05-12 2013-07-09 Genzyme Corporation Modulators of tnf- alpha signaling

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA811340B (en) * 1980-06-09 1982-03-31 Morton Norwich Products Inc N-(cycloalkyl)amino acid compounds
AU1995392A (en) * 1991-05-08 1992-12-21 Mallinckrodt Medical, Inc. Technetium chelates to be used for determining the renal function
JPH0570484A (ja) * 1991-09-12 1993-03-23 Hitachi Chem Co Ltd ペプチドおよびその塩
CA2129036A1 (en) * 1992-02-06 1993-08-19 Mallinckrodt Inc. Ligands for improving metal chelate formation kinetics
ATE196094T1 (de) * 1992-05-21 2000-09-15 Diatide Inc Technetium-99m markierte peptide zur bilderzeugung von thrombus
DE4311021A1 (de) * 1993-03-31 1994-10-27 Diagnostikforschung Inst Bifunktionelle Chelatbildner, deren Technetium- und Rhenium-Komplexe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende radiopharmazeutische Mittel

Also Published As

Publication number Publication date
ZA948411B (en) 1995-06-30
WO1995012610A1 (de) 1995-05-11
CA2173844A1 (en) 1995-05-11
DE4337600A1 (de) 1995-05-04
HUT74881A (en) 1997-02-28
AU8103894A (en) 1995-05-23
EP0726909A1 (de) 1996-08-21
KR960705842A (ko) 1996-11-08
CN1134158A (zh) 1996-10-23
NO961743L (no) 1996-04-30
AU681919B2 (en) 1997-09-11
JPH09508351A (ja) 1997-08-26
HU9601140D0 (en) 1996-07-29

Similar Documents

Publication Publication Date Title
EP0344724A3 (en) Metal radionuclide chelating compounds for improved chelation kinetics
NO950123D0 (no) Paratyreoidea hormonforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende disse
AU3778989A (en) Diaminedithiol chelating agents for radiopharmaceuticals
AU1378395A (en) Metal chelators
IT8547596A0 (it) Composti chelanti per la riduzione di ioni metallici contenuti nei tessuti corporei, in particolare ferro, composizioni farmaceutiche contenenti tali composti e procedimento di preparazione
NO953457D0 (no) Somatostatinpeptider, fremgangsmåte for deres fremstilling, farmasöytiske preparater derav og anvendelse
IS4189A (is) Joðuð fáliða efnasambönd og efnasambönd til greiningar sem innihalda þau
ZA945497B (en) Design optimized compositions and processes for microstructurally engineering cementitious mixtures
GB8802788D0 (en) Composition & process for treating metal surfaces
AR001781A1 (es) Péptido formando quelato metálico reactivo marcadocon radionucleido metálico composición de radiodiagnostico composición radioterapéutica y peptido fisiologicamente activo que lo comprenden y método de preparación de dichos compuestos y composiciones
NO961743D0 (no) N-alkyl-peptid-chelatdannere, deres metallkomplekser med radionuklider, fremgangsmåte ved deres fremstilling og radiofarmasöytiske sammensetninger inneholdende disse forbindelser
NO953865L (no) Bifunksjonelle chelatorer og deres anvendelse i radiofarmasöytiske midler
GB2241234B (en) Betaine compound and detergent composition
NO962243D0 (no) Halogenarylsubstituerte metallkomplekser, farmasöytiske midler inneholdende slike og deres anvendelse i diagnostikken, samt fremgangsmåte for fremstilling av slike komplekser og midler
PT80841A (en) Process for the preparation of compounds for site-enhanced delivery of radionuclides and of chelating agents useful therefor
GB9325323D0 (en) Decontamination of metals
EP0792170A4 (en) METAL CHELATES OF RADIONUCLIDES USED FOR RADIOTARKING LIGANDS, ANTI-LIGANDS AND OTHER PROTEINS
NO961744D0 (no) Metallbindende, cysteinfrie peptider for diagnose og terapi, fremgangsmåte ved deres fremstilling og radiofarmasöytiske sammensetninger inneholdende disse forbindelser
DE3366175D1 (en) Metal extraction from solution and immobilized chelating agents used therefor
DK0423286T3 (da) Fremgangsmåde og komposition til beskyttelse af og til forbedring af lodbarheden for metalliske overflader
GB2235448B (en) Boronic acid adducts of technetium-99m dioxime complexes
PT80842A (en) Process for the preparation of novel radiopharmaceuticals and of chelating agents useful in their preparation
GB2228491B (en) Dissolving solution for metal compounds containing dibutyl phosphate ions and decontamination process using this solution
GB2281079B (en) Subliming solder flux composition
NZ211192A (en) Bis(aminomethyl)bicyclo(2.2.1)heptane derivatives as chelating agents, as metal ion precipitating inhibitors and as radioactive bone seeking complexes